Nalumaga Pauline Petra

Mrs. Nalumaga Pauline Petra


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2025 in PLOS ONE
Verified
Journal Article
Open access
PDF file
TSThomas Ssemakadde
Thomas Ssemakadde
NPNalumaga Pauline Petra
Nalumaga Pauline Petra
JBJude Collins Busingye
Jude Collins Busingye
JBJoel Bazira
Joel Bazira
KTKabanda Taseera
Kabanda Taseera
Background: The emergence and re-emergence of zoonotic bacterial infections and the upsurge reflected in current trends of antimicrobial-resistant bacteria is a major global concern. Salmonella spp and Escherichia coli (E. coli) are the two most important food-borne pathogens of public health interest incriminated in poultry products worldwide. AMR in poultry farming poses a significant public health risk in Uganda, as the misuse and overuse of antibiotics in livestock can lead to the emergence of resistant pathogens that may transfer to humans through direct contact, consumption of contaminated poultry products, or environmental exposure, further complicating the management of infection hence necessitating constant monitoring of microbial food safety measures. Methods: This study was a cross-sectional study that used a total of two hundred sixteen poultry samples from cloacae swabs and fecal swabs collected from broiler poultry farms. These were cultured on Chromagar TM Salmonella and Sorbitol MacConkey agar. Biochemical tests, minimum inhibitory concentration, and polymerase chain reaction were utilized. Data was analyzed by descriptive statistics, and Chi-square (χ²) Test statistical significance of quantitative data. Results: A total of 40 (18.5%) Salmonella and 120 (55.6%) pathogenic E. coli were isolated while extended beta-lactamase (ESBL) production was detected in 18 Salmonella and 57 pathogenic E. coli isolates. Prevalence of blaTEM gene was expressed in 7/18 (39%) Salmonella isolates and 42/57 (73.8%) Pathogenic E. coli isolates The significant associated factors that predisposed these farms to Salmonella spp was source of poultry feeds (p-value = 0.066) while factors associated with pathogenic E. coli included contact of poultry with other birds and livestock (p-value = 0.020), movement from one pen to the other by farm-handlers (p-value = 0.017), use of untreated water (p-value = 0.018) and food contamination of commercial poultry feeds (p-value = 0.0021). Conclusion: The findings of this study highlight the significant presence of Salmonella and pathogenic E. coli in poultry farms, underscoring the potential risks to public health. The high prevalence of antimicrobial resistance observed among these isolates calls for urgent interventions to curb the misuse of antibiotics in poultry farming.

1 August 2025 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
JBJoel Bazira
Joel Bazira
NPNalumaga Pauline Petra
Nalumaga Pauline Petra
CNConstance Nakimuli Nakato
Constance Nakimuli Nakato
AWAbel Wilson Walekhwa
Abel Wilson Walekhwa
BNBrenda Nakazibwe
Brenda Nakazibwe
SKSimon Kawuma
Simon Kawuma
Background: Urinary tract infections (UTIs) are among the most common bacterial infections globally, with significant morbidity and rising antimicrobial resistance (AMR). This study aimed to investigate the prevalence of uropathogens and their antimicrobial resistance patterns at Mbarara Regional Referral Hospital (MRRH) in Uganda. Methods: A retrospective analysis of 939 urine culture- positive records from January 2019 to December 2024 was conducted. Isolates were identified, and antimicrobial susceptibility testing was performed using the disc diffusion method. Data on patient demographics, uropathogen distribution, and resistance trends of organisms with greater than or equal to 25 isolates were analyzed using Python-based statistical methods, including Chi-square and Mann–Kendall trend analysis. Results: Escherichia coli was the most isolated pathogen, accounting for 428 isolates (45.6%), followed by Klebsiella spp. with 385 isolates (41.0%) while Citrobacter spp. and Enterococcus spp. contributed 42 (4.5%) and 26 (2.8%) isolates, respectively. The cases were dominated by females (69.0%). There was an extremely high resistance to commonly prescribed antibiotics such as ampicillin (91.3%) and sulfamethoxazole (91.6%). Carbapenem resistance was overall low (≤ 10.3%) but also had a statistically significant rising trend in Klebsiella spp. (p = 0.0415). Multidrug resistance (MDR) was present in 56.9% of the isolates, predominantly in Escherichia coli and Klebsiella spp. and 70% of the MDR isolates were ESBL producers. Conclusion: This study underscores the urgent need for routine culture and sensitivity, and updated treatment guidelines to address the rising AMR among uropathogens in Uganda.

1 January 2025 in Canadian Journal of Infectious Diseases and Medical Microbiology
Verified
Journal Article
Open access
JBJoel Bazira
Joel Bazira
NPNalumaga Pauline Petra
Nalumaga Pauline Petra
BQBalukhu Quraishi
Balukhu Quraishi
AWAbel W Walekhwa
Abel W Walekhwa
LMLawrence Mugisha
Lawrence Mugisha
JIJacob Stanley Iramiot
Jacob Stanley Iramiot
Introduction: Antimicrobial resistance remains a global threat, with increasing infection and death rates. The World Health Organization identified Enterococcus faecium , Staphylococcus aureus , Klebsiella pneumoniae , Acinetobacter baumannii , Pseudomonas aeruginosa , and Enterobacter spp. (ESKAPE) as priority pathogens due to their increased antibiotic resistance development. This study assessed the resistance patterns of ESKAPE pathogens from 2015 to 2022 in Mbarara Regional Referral Hospital, Uganda. Methods: A retrospective study was conducted by reviewing retrieved data from WHONET. This is the laboratory software used in the microbiology laboratory in the Department of Microbiology, Mbarara University of Science and Technology (MUST), which receives samples from both the outpatient and the inpatient departments of Mbarara Regional Referral Hospital. Results: A total of 5733 bacterial isolates were recovered, of which, 4822 were ESKAPE pathogens from the collected clinical specimens including blood, stool, urine, swabs, cerebral spinal fluid, wounds, and sputum. Staphylococcus aureus (4291, 74.8%) was the most frequently isolated pathogen followed by Klebsiella pneumoniae (345, 6.0%). The bacteria categorized as ESKAPE pathogens showed significant rates of multidrug resistance. Ampicillin showed the highest resistance followed by ciprofloxacin. Conclusion: The significant prevalence of antimicrobial resistance to penicillin, ciprofloxacin, and tetracycline in ESKAPE bacteria emphasizes the significance of enhancing antimicrobial surveillance and infection‐prevention and management initiatives within the country.

15 August 2023 in JMIR Research Protocols
Verified
Journal Article
Open access
INIsrael Kiiza Njovu
Israel Kiiza Njovu
NPNalumaga Pauline Petra
Nalumaga Pauline Petra
LALucas Ampaire
Lucas Ampaire
ENEdwin Nuwagira
Edwin Nuwagira
JMJames Mwesigye
James Mwesigye
HIHerbert Itabangi
Herbert Itabangi
Background: Fungal-bacterial cocolonization and coinfections pose an emerging challenge among patients suspected of having pulmonary tuberculosis (PTB); however, the underlying pathogenic mechanisms and microbiome interactions are poorly understood. Understanding how environmental microbes, such as fungi and bacteria, coevolve and develop traits to evade host immune responses and resist treatment is critical to controlling opportunistic pulmonary fungal coinfections. In this project, we propose to study the coexistence of fungal and bacterial microbial communities during chronic pulmonary diseases, with a keen interest in underpinning fungal etiological evolution and the predominating interactions that may exist between fungi and bacteria. Objective: This is a protocol for a study aimed at investigating the metabolic and molecular ecological evolution of opportunistic pulmonary fungal coinfections through determining and characterizing the burden, etiological profiles, microbial communities, and interactions established between fungi and bacteria as implicated among patients with presumptive PTB. Methods: This will be a laboratory-based cross-sectional study, with a sample size of 406 participants. From each participant, 2 sputa samples (one on-spot and one early morning) will be collected. These samples will then be analyzed for both fungal and bacterial etiology using conventional metabolic and molecular (intergenic transcribed spacer and 16S ribosomal DNA–based polymerase chain reaction) approaches. We will also attempt to design a genome-scale metabolic model for pulmonary microbial communities to analyze the composition of the entire microbiome (ie, fungi and bacteria) and investigate host-microbial interactions under different patient conditions. This analysis will be based on the interplays of genes (identified by metagenomics) and inferred from amplicon data and metabolites (identified by metabolomics) by analyzing the full data set and using specific computational tools. We will also collect baseline data, including demographic and clinical history, using a patient-reported questionnaire. Altogether, this approach will contribute to a diagnostic-based observational study. The primary outcome will be the overall fungal and bacterial diagnostic profile of the study participants. Other diagnostic factors associated with the etiological profile, such as incidence and prevalence, will also be analyzed using univariate and multivariate schemes. Odds ratios with 95% CIs will be presented with a statistical significance set at P<.05. Results: The study has been approved by the Mbarara University Research Ethic Committee (MUREC1/7-07/09/20) and the Uganda National Council of Science and Technology (HS1233ES). Following careful scrutiny, the protocol was designed to enable patient enrollment, which began in March 2022 at Mbarara University Teaching Hospital. Data collection is ongoing and is expected to be completed by August 2023, and manuscripts will be submitted for publication thereafter. Conclusions: Through this protocol, we will explore the metabolic and molecular ecological evolution of opportunistic pulmonary fungal coinfections among patients with presumptive PTB. Establishing key fungal-bacterial cross-kingdom synergistic relationships is crucial for instituting fungal bacterial coinfecting etiology. Trial Registration: ISRCTN Registry ISRCTN33572982; https://tinyurl.com/caa2nw69 International Registered Report Identifier (IRRID): DERR1-10.2196/48014

6 July 2025 in Scientific Reports
Verified
Journal Article
Open access
PDF file
NMNusifah Mbatudde
Nusifah Mbatudde
NPNalumaga Pauline Petra
Nalumaga Pauline Petra
JBJoel Bazira
Joel Bazira
TKTaseera Kabanda
Taseera Kabanda
Vulvovaginal candidiasis (VVC) represents a universal health hazard that contributes to significant morbidity in HIV-positive women. Antifungal resistance is a worldwide increasing health problem that reduces treatment options while increasing treatment costs. The purpose of this study was to determine the prevalence of VVC, identify associated risk factors, characterize the distribution of Candida species, and assess their antifungal susceptibility patterns among HIV-positive women attending Mbarara City Health Centre IV. A laboratory-based, cross-sectional study design was conducted on 146 high vaginal swabs collected from HIV- positive women aged 18 years and above attending routine HIV care that presented with signs and symptoms of vulvovaginal candidiasis. These were subjected to microscopy and culture on Sabouraud Dextrose Agar. Candida isolates were identified by gram stain, germ tube, CHROM agar™, and Analytical profile index (API® Candida) tests. Susceptibility to fluconazole, clotrimazole, voriconazole, amphotericin B, miconazole, and nystatin by the disc diffusion method on Mueller Hinton agar supplemented with 2%w/v glucose and 0.5 µg/ml methylene blue dye. Out of the 146 high vaginal swabs collected, 71(49%) were colonized with Candida species with 43(62%) being Candida albicans while 26 (37.6%) were non-Candida albicans. Candida species were susceptible to amphotericin B (68/71, 95.7%) and resistant to fluconazole and clotrimazole (33/71, 45%). Elevated blood glucose levels were significantly associated with vulvovaginal candidiasis (p = 0.018; odds ratio = 2.93). Candida albicans is the leading cause of VVC, with a higher prevalence than non-Candida albicans. It also demonstrates that amphotericin B and nystatin are the most effective antifungal medications. Furthermore, diabetes is associated with VVC compared to other studied factors. We recommend the use of nystatin for the management of vulvovaginal candidiasis among HIV adult women.

1 March 2025 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
CNChristopher Ndawula
Christopher Ndawula
NPNalumaga Pauline Petra
Nalumaga Pauline Petra
FWFredrickson B Wasswa
Fredrickson B Wasswa
JBJoel Bazira
Joel Bazira
Background: Globally, 10.8 million people were diagnosed with tuberculosis during 2023 causing approximately 1.3 million deaths. This study aimed to assess the prevalence and characterization of pyrazinamide resistance by detecting the pncA gene among newly diagnosed Mycobacterium tuberculosis patients attending Bombo General Military Hospital, Central Uganda. Methods: Cross-sectional study looking at newly diagnosed TB patients in Bombo General Military Hospital. The sputum samples were confirmed TB positive using GeneXpert PCR technology, DNA extraction using the CTAB method, DNA amplification, and finally gel electrophoresis for pncA gene detection. Results: A total of 166 sputum-positive tuberculosis samples were analyzed. Males were 91/166 (55%), while 115 (70%) of the positive sputum samples were positive HIV status. The majority (96%) of the newly diagnosed Mycobacterium tuberculosis patients showed no detection of rifampicin resistance, while the rest 6/160 (4%) showed indeterminate rifampicin resistance. Of the 52 (31%) patients with positive pncA gene, 29 (56%) had HIV positive status 18 (34%) had unknown HIV status and 5 (10%) had negative HIV status. It was observed that only one patient 1 (2%) showed both rifampicin and pyrazinamide resistance and was a female patient aged 42 years of age with positive HIV status and positive pncA gene status. Conclusion: This study reveals the important trends regarding drug resistance and its relationship with HIV status. The majority of patients (96%) did not exhibit rifampicin resistance, suggesting that multi-drug-resistant tuberculosis is not widespread among the newly diagnosed cases. The majority (56%) of the patients with the pncA gene mutation, were HIV-positive. This highlights the potential vulnerability of HIV-positive TB patients to multidrug resistance though the overall pyrazinamide resistance rate remains low.